Neurophysiological basis of rapid eye movement sleep behavior disorder: informing future drug development

Poul Jennum, Julie AE Christensen, Marielle Zoetmulder Department of Clinical Neurophysiology, Faculty of Health Sciences, Danish Center for Sleep Medicine, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark Abstract: Rapid eye movement (REM) sleep behavior disorder (RBD) is a parasomnia...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Jennum P, Christensen JAE, Zoetmulder M
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2016
Materias:
Acceso en línea:https://doaj.org/article/603a053a4a02451799ef322785661317
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:603a053a4a02451799ef322785661317
record_format dspace
spelling oai:doaj.org-article:603a053a4a02451799ef3227856613172021-12-02T06:30:22ZNeurophysiological basis of rapid eye movement sleep behavior disorder: informing future drug development1179-1608https://doaj.org/article/603a053a4a02451799ef3227856613172016-04-01T00:00:00Zhttps://www.dovepress.com/neurophysiological-basis-of-rapid-eye-movement-sleep-behavior-disorder-peer-reviewed-article-NSShttps://doaj.org/toc/1179-1608Poul Jennum, Julie AE Christensen, Marielle Zoetmulder Department of Clinical Neurophysiology, Faculty of Health Sciences, Danish Center for Sleep Medicine, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark Abstract: Rapid eye movement (REM) sleep behavior disorder (RBD) is a parasomnia characterized by a history of recurrent nocturnal dream enactment behavior and loss of skeletal muscle atonia and increased phasic muscle activity during REM sleep: REM sleep without atonia. RBD and associated comorbidities have recently been identified as one of the most specific and potentially sensitive risk factors for later development of any of the alpha-synucleinopathies: Parkinson’s disease, dementia with Lewy bodies, and other atypical parkinsonian syndromes. Several other sleep-related abnormalities have recently been identified in patients with RBD/Parkinson’s disease who experience abnormalities in sleep electroencephalographic frequencies, sleep–wake transitions, wake and sleep stability, occurrence and morphology of sleep spindles, and electrooculography measures. These findings suggest a gradual involvement of the brainstem and other structures, which is in line with the gradual involvement known in these disorders. We propose that these findings may help identify biomarkers of individuals at high risk of subsequent conversion to parkinsonism. Keywords: motor control, brain stem, hypothalamus, hypocretinJennum PChristensen JAEZoetmulder MDove Medical PressarticleREM sleep Behavior DisorderelectrophysiologyneurophysiologypolysomnographytreatmentParkinsonsleepPsychiatryRC435-571Neurophysiology and neuropsychologyQP351-495ENNature and Science of Sleep, Vol 2016, Iss Issue 1, Pp 107-120 (2016)
institution DOAJ
collection DOAJ
language EN
topic REM sleep Behavior Disorder
electrophysiology
neurophysiology
polysomnography
treatment
Parkinson
sleep
Psychiatry
RC435-571
Neurophysiology and neuropsychology
QP351-495
spellingShingle REM sleep Behavior Disorder
electrophysiology
neurophysiology
polysomnography
treatment
Parkinson
sleep
Psychiatry
RC435-571
Neurophysiology and neuropsychology
QP351-495
Jennum P
Christensen JAE
Zoetmulder M
Neurophysiological basis of rapid eye movement sleep behavior disorder: informing future drug development
description Poul Jennum, Julie AE Christensen, Marielle Zoetmulder Department of Clinical Neurophysiology, Faculty of Health Sciences, Danish Center for Sleep Medicine, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark Abstract: Rapid eye movement (REM) sleep behavior disorder (RBD) is a parasomnia characterized by a history of recurrent nocturnal dream enactment behavior and loss of skeletal muscle atonia and increased phasic muscle activity during REM sleep: REM sleep without atonia. RBD and associated comorbidities have recently been identified as one of the most specific and potentially sensitive risk factors for later development of any of the alpha-synucleinopathies: Parkinson’s disease, dementia with Lewy bodies, and other atypical parkinsonian syndromes. Several other sleep-related abnormalities have recently been identified in patients with RBD/Parkinson’s disease who experience abnormalities in sleep electroencephalographic frequencies, sleep–wake transitions, wake and sleep stability, occurrence and morphology of sleep spindles, and electrooculography measures. These findings suggest a gradual involvement of the brainstem and other structures, which is in line with the gradual involvement known in these disorders. We propose that these findings may help identify biomarkers of individuals at high risk of subsequent conversion to parkinsonism. Keywords: motor control, brain stem, hypothalamus, hypocretin
format article
author Jennum P
Christensen JAE
Zoetmulder M
author_facet Jennum P
Christensen JAE
Zoetmulder M
author_sort Jennum P
title Neurophysiological basis of rapid eye movement sleep behavior disorder: informing future drug development
title_short Neurophysiological basis of rapid eye movement sleep behavior disorder: informing future drug development
title_full Neurophysiological basis of rapid eye movement sleep behavior disorder: informing future drug development
title_fullStr Neurophysiological basis of rapid eye movement sleep behavior disorder: informing future drug development
title_full_unstemmed Neurophysiological basis of rapid eye movement sleep behavior disorder: informing future drug development
title_sort neurophysiological basis of rapid eye movement sleep behavior disorder: informing future drug development
publisher Dove Medical Press
publishDate 2016
url https://doaj.org/article/603a053a4a02451799ef322785661317
work_keys_str_mv AT jennump neurophysiologicalbasisofrapideyemovementsleepbehaviordisorderinformingfuturedrugdevelopment
AT christensenjae neurophysiologicalbasisofrapideyemovementsleepbehaviordisorderinformingfuturedrugdevelopment
AT zoetmulderm neurophysiologicalbasisofrapideyemovementsleepbehaviordisorderinformingfuturedrugdevelopment
_version_ 1718399872898433024